ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease-Reference-Cited by-同舟云学术

ROS-responsive nano-medicine for navigating autophagy to enhance targeted therapy of inflammatory bowel disease

Published:2024-06 Issue: Volume:659 Page:124117
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Chen You,Feng Juewen,Chen Yang,Xia Chuanhe,Yao Min,Ding Wenxing,Li Xiang,Fu Xiuzhi,Zheng Shulei,Ma Yin,Zou Jiafeng,Lan Minbo,Gao Feng

Publisher

Elsevier BV

Reference52 articles.

1. Defining the role of sirolimus in the management of graft-versus-host disease: From prophylaxis to treatment;Abouelnasr;Blood Marrow Transplant.,2013

2. NF-kappaB in inflammatory bowel disease;Atreya;J. Intern. Med.,2008

3. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms;Banan;J. Pharmacol. Exp. Ther.,1999

4. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: Role of the microtubule cytoskeleton;Banan;Free Radic. Biol. Med.,2000

5. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features;Bellomo;J. Cell. Physiol.,1990

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy;Journal of Nanobiotechnology;2024-08-27

2. Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment;Drug Design, Development and Therapy;2024-07